发明名称 INSPECTION METHOD USING MARKER OF LEUKOCYTE ANTIGEN
摘要 PROBLEM TO BE SOLVED: To provide an inspection method for predicting the onset of drug-induced interstitial lung diseases (DI-ILD), more specifically, to provide a marker for a prediction inspection of the onset of DI-ILD.SOLUTION: Risk of the onset of DI-ILD can be predicted by detecting a specific HLA allele which is a human leukocyte antigen, namely HLA-A*31:01. A patient that has highly possibility to develop DI-ILD can be specified by detecting the HLA allele, namely HLA-A*31:01, specified by an inspection method of the present invention as a marker, in patients that have diseases to be administered a pharmaceutical agent that may induce interstitial lung diseases. Thereby, the specified patient that has high possibility to develop DI-ILD can obtain an opportunity to select and determine administration of a pharmaceutical agent that hardly induces interstitial lung diseases and a treatment plan.
申请公布号 JP2014093962(A) 申请公布日期 2014.05.22
申请号 JP20120246480 申请日期 2012.11.08
申请人 JAPAN HEALTH SCIENCES FOUNDATION 发明人 TOMA SHIGETO;FURUKAWA HIROSHI
分类号 C12Q1/68;C12N15/09 主分类号 C12Q1/68
代理机构 代理人
主权项
地址